Upload
jarvis
View
224
Download
0
Embed Size (px)
Citation preview
8/2/2019 Patents in Biotechnology: What, How & Why?
1/32
Patents in Biotechnology:
What, how & why?Dr Anton Hutter
Chartered & European Patent Attorney
January 2012
8/2/2019 Patents in Biotechnology: What, How & Why?
2/32
Patents: What, how & why?
What are they & what do they protect?How to apply for & get a granted patent
Patentability requirements Inventorship & ownership issues How to get a granted patent
Why file a patent application? Uses of patents Investing in IP
8/2/2019 Patents in Biotechnology: What, How & Why?
3/32
Patents: What?
8/2/2019 Patents in Biotechnology: What, How & Why?
4/32
Patents
Protect technical inventionsA patent is an exclusive right allowing the owner to preventthird parties from doing certain things in respect of the claimedinvention:-
- making
- using- selling (offering to sell)
- importing- keeping
Patent lasts for 20 years from filing dateTerritorial nature of patentsPost-grant infringement and validity usually judged in nationalcourts
8/2/2019 Patents in Biotechnology: What, How & Why?
5/32
Patents as a monopoly
The monopoly or scope of protection is defined by the claims: Products/articles/compositions Processes/methods/uses
Careful claim drafting required to maximise scope of protection
8/2/2019 Patents in Biotechnology: What, How & Why?
6/32
What is patentable in bioscience?
Chemical and biological compoundsper se Biological materials (nucleotides, constructs, peptides,
proteins, antibodies etc.)
Primary, secondary & tertiary structures of macromolecules Processes formaking them Processes forusing them Substances useful in these processes, e.g. enzymes Cell lines, micro-organisms, transgenic organisms and plants
8/2/2019 Patents in Biotechnology: What, How & Why?
7/32
What is patentable in bioscience?
Analytical/diagnostic methods Medical uses Drug delivery Dosage regimens Exclusions where contrary to morality : no
protection for processes for cloning human beings,
using human embryos for commercial purposes etc.
8/2/2019 Patents in Biotechnology: What, How & Why?
8/32
Patents: How?
8/2/2019 Patents in Biotechnology: What, How & Why?
9/32
Patentability
Requirements
8/2/2019 Patents in Biotechnology: What, How & Why?
10/32
1) Novelty
In Europe, there is an absolute novelty requirementAt date of filing, invention must not have been made available to thepublic:
- in any way
- in any language
- at any time
- anywhere
- by anyone
Examples:-
- Academic paper
- Publication of an abstract on internet
- Public presentation or lecture
- Poster at a conference
- Open discussions at a conference- PhD Thesis
- Sale of a product- Non-confidential use of a product
8/2/2019 Patents in Biotechnology: What, How & Why?
11/32
Confidentiality
Invention must be confidential before application filed Be careful what you disclose & what you keep secret Difficult in academia due to collaborations with other institutions
Take care when trying to attract funding, writing grantproposals & promoting your work
Use a confidentiality agreement if disclosing to 3rd parties Err on the side of caution and disclosenothing until a patent
application has been filed
8/2/2019 Patents in Biotechnology: What, How & Why?
12/32
2) Inventive Step
Invention must not be obvious over the prior art and common generalknowledge
Prior art is everything that was in the public domain before the patentapplication was filed
Inventive step is arguable:-- Unexpected orsurprising result?
- Use ofnon-routine techniques?
- Not obvious to try?
8/2/2019 Patents in Biotechnology: What, How & Why?
13/32
Other patentability requirements
3) Industrial Applicability
Invention must be capable of being applied in industry/agricultureMention at least one use in the patent applicationNeeded at filing date!
8/2/2019 Patents in Biotechnology: What, How & Why?
14/32
Other patentability requirements
4) Sufficiency
The patent specification must be sufficiently detailed so that a personskilled in the art can repeat the invention without undue burden
Include full details of all non-routine techniques usedNeeded at filing date!
8/2/2019 Patents in Biotechnology: What, How & Why?
15/32
Other patentability requirements
5) Support
Include example(s) to prove the claimed invention actually worksIn vitro & in vivo dataNeeded at filing date!
8/2/2019 Patents in Biotechnology: What, How & Why?
16/32
Inventorship &
ownership issues
8/2/2019 Patents in Biotechnology: What, How & Why?
17/32
Inventorship
Important to sort this out at the outsetThe inventor is the actual deviser of the inventionMay be a team, consider, e.g.
- Academics professors, lecturers, post-docs, post-grads, PhD
students, undergrads, students- Consultants- External contractors
- Employees
- Company directors
Multi-disciplinary teams becoming more common
8/2/2019 Patents in Biotechnology: What, How & Why?
18/32
Ownership
The ownerdepends on the relationship between inventor(s) and otherparties involved
Usually owned by employer (employed to invent?)Contract?In academia, the university usually owns the IPIP may subsequently be assigned from university to spin-out
8/2/2019 Patents in Biotechnology: What, How & Why?
19/32
How to get a granted
patent
8/2/2019 Patents in Biotechnology: What, How & Why?
20/32
0 monthsFile UK application
(1.5k-4k)
+12 months
File international (PCT) application(3k-5k)
+15 months
International Search & Written Opinion(200)
+18 monthsInternational publication
+31 monthsFile European application
All designations(3.5k)
+30/31 monthsFile national applications
(1k-5k each)
For example:-
AustraliaBrazil
CanadaChina
IndiaJapan
Russia
USA
+60 months
GRANT OF EUROPEAN PATENTComplete formalities and register NATIONALLY
(500-5k per country)
For example:-
AustriaFrance
GermanyItaly
The NetherlandsUK
Patent
Filing
Procedure
8/2/2019 Patents in Biotechnology: What, How & Why?
21/32
8/2/2019 Patents in Biotechnology: What, How & Why?
22/32
Patents: Why?
8/2/2019 Patents in Biotechnology: What, How & Why?
23/32
Uses of Patents
8/2/2019 Patents in Biotechnology: What, How & Why?
24/32
Patents are Commercial Tools
When building a patent portfolio, be clear about yourcommercial aims:
- Attracting funding/investment?
- Spin-out or equivalent?
- Create an income stream (licensing royalties)?
- As a bargaining chip in negotiations?
- Deterrent effect against competitors?
- Create barrier to others to enter market
- Seeking a collaboration?
8/2/2019 Patents in Biotechnology: What, How & Why?
25/32
When to file?
A serious commercial opportunity is likely to require filing a patentapplication, even if ultimately obtaining patent protection may be
challenging
However, if the commercial opportunity is small, a patent application maynot be justified, even if the invention is eminently patentable
File patent
application
Do not file patent
application
8/2/2019 Patents in Biotechnology: What, How & Why?
26/32
Investing in IP
8/2/2019 Patents in Biotechnology: What, How & Why?
27/32
Due diligence
Much more than simply listing a company
s IP portfolio
An assessment of:-(i) the strength of a companys IP;
(ii) the strength of your competitors rights
Crucial to getting funding
8/2/2019 Patents in Biotechnology: What, How & Why?
28/32
What are investors looking for?
1.
Check entitlement
2. Check the inventors are correctly named3. Assess patentability with respect to the prior art4. Assess validity with respect to sufficiency & support
8/2/2019 Patents in Biotechnology: What, How & Why?
29/32
What are investors looking for?
5.
Check if company has strong patent portfolio offering goodprotection
6. Check the numbers of patent families offering different breadths ofprotection
7. Check geographical coverage of protection8. Check remaining term of patent protection9. Check the company has freedom-to-operate
8/2/2019 Patents in Biotechnology: What, How & Why?
30/32
Freedom-to-operate
Look for any dominating patent rights You may require a licence to even work
in your area
Consider cross-licensing If you have to pay royalties, this may make your commercial venture
economically unviable
Without clearance for the market you wish to enter, there is always asignificant risk that you will be barred, or at least have to pay aroyalty stack to proceed with your business
8/2/2019 Patents in Biotechnology: What, How & Why?
31/32
Summary A patent is an exclusive right allowing you to prevent a third party from
working your invention
BUT, you need freedom-to-operate to work the invention yourself File patent applications where commercial opportunities are good, even
if ultimately obtaining broad protection may be difficult
Novelty, inventive step, industrial application, sufficiency and support Important to get inventorship & ownership issues right at outset Due diligence will be carried out on your patent portfolio, so think ahead Be clear about your commercial aims
8/2/2019 Patents in Biotechnology: What, How & Why?
32/32
Anton HutterBSc MSc PhD CPA EPA
Chartered & European Patent Attorney
Venner Shipley LLP
200 Aldersgate
London
EC1A 7HD
Tel: 020 7600 4212
Fax: 020 7600 4188
W: www.vennershipley.co.uk